← Evidence map

ArticleBMJ open2026

Supporting adherence to adjuvant CDK4/6 inhibitors in women with early breast cancer (SWEET-PLUS): protocol for a multicentre UK study using qualitative and co-development methods.

Pearlin Teow et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Supporting adherence to adjuvant CDK4/6 inhibitors in women with early breast cancer (SWEET-PLUS): protocol for a multicentre UK study using qualitative and co-development methods. | Socratic